Risks | |
Understanding the “Black Box” of Employer Decisions about Health Insurance Benefits: The Case of Depression Products | |
Kathryn Rost1  Airia Papadopoulos1  Su Wang1  | |
[1] Department of Mental Health Law and Policy, College of Behavioral and Community Sciences, 13301 Bruce B. Downs Blvd., University of South Florida, Tampa FL 33612, USA; E-Mails: | |
关键词: : health benefits; insurance; depression; employers; return on investment; productivity; absenteeism; collaborative care; | |
DOI : 10.3390/risks1010034 | |
来源: mdpi | |
![]() |
【 摘 要 】
In a randomized trial of two interventions on employer health benefit decision-making, 156 employers in the evidence-based (EB) condition attended a two hour presentation reviewing scientific evidence demonstrating depression products that increase high quality treatment of depression in the workforce provide the employer a return on investment. One-hundred sixty-nine employers participating in the usual care (UC) condition attended a similar length presentation reviewing scientific evidence supporting healthcare effectiveness data and information set (HEDIS) monitoring. This study described the decision-making process in 264 (81.2%) employers completing 12 month follow-up. The EB intervention did not increase the proportion of employers who discussed depression products with others in the company (29.2%
【 授权许可】
CC BY
© 2013 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190036114ZK.pdf | 175KB | ![]() |